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OBJECTIVE — Weevaluatedwhetherawheypreloadcouldslowgastricemptying,stimulate
incretin hormones, and attenuate postprandial glycemia in type 2 diabetes.
RESEARCH DESIGN AND METHODS — Eight type 2 diabetic patients ingested 350
mlbeefsoup30minbeforeapotatomeal;55gwheywasaddedtoeitherthesoup(wheypreload)
or potato (whey in meal) or no whey was given.
RESULTS — Gastric emptying was slowest after the whey preload (P  0.0005). The incre-
mentalareaunderthebloodglucosecurvewaslessafterthewheypreloadandwheyinmealthan
after no whey (P  0.005). Plasma glucose-dependent insulinotropic polypeptide, insulin, and
cholecystokinin concentrations were higher on both whey days than after no whey, whereas
glucagon-like peptide 1 was greatest after the whey preload (P  0.05).
CONCLUSIONS — Whey protein consumed before a carbohydrate meal can stimulate in-
sulin and incretin hormone secretion and slow gastric emptying, leading to marked reduction in
postprandial glycemia in type 2 diabetes.
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T
he rate of gastric emptying and the
incretin, glucagon-like peptide 1
(GLP-1) and glucose-dependent in-
sulinotropic polypeptide (GIP), response
to a meal are known to be major determi-
nants of postprandial blood glucose ex-
cursions (1,2). One strategy to minimize
postprandialglycemiacouldbetoadmin-
ister a small load of protein or fat before a
meal, so that the presence of nutrients in
the small intestine induces the release of
peptides such as GLP-1, GIP, and chole-
cystokinin (CCK) to slow gastric empty-
ing and stimulate insulin secretion in
advance of the main nutrient load (3,4).
We hypothesized that a protein preload
would reduce the postprandial glycemic
excursion in type 2 diabetic patients by
these mechanisms.
RESEARCH DESIGN AND
METHODS— The protocol included
eight diet-controlled type 2 diabetic pa-
tients(sevenmale,meanSEage583
years, BMI 28.6  1.3 kg/m
2, duration of
knowndiabetes5.41.1years,andA1C
6.5  0.2%) who attended the labora-
tory after an overnight fast (14 h for
solids and 12 h for liquids) on three
separate occasions. Each patient con-
sumed beef-ﬂavored soup (3.8 g nonca-
loric beef ﬂavoring dissolved in 350 ml
water) 30 min before a mashed potato
meal containing 65 g powdered potato
(Deb Instant Mashed Potato, Epping,
Australia) with 20 g glucose (total:
59.1gcarbohydrate,4.3gfat,5.2gpro-
tein; 1,276.5 kJ), labeled with 20 MBq
99mTc-sulfur colloid (4). On one day,
55 g whey protein (876.7 kJ) was added
to the soup. On another day, 55 g whey
was mixed into the potato meal. On a
third day, neither the preload nor the
meal contained whey. Blood was sam-
pled frequently for blood glucose and
plasma hormone measurements.
Measurements
Gastric emptying was assessed by scintig-
raphy. Data were corrected for radio-
nuclide decay, subject movement, and
-ray attenuation, and the gastric half-
emptying time (T50) was calculated
(4).
Blood glucose concentrations were
measured using a glucometer (Medisense
Precision QID; Abbott Laboratories, Bed-
ford, MA), which we have validated
against the hexokinase technique (5).
Plasma insulin was measured by enzyme-
linked immunosorbent assay (ELISA; Di-
agnostic Systems Laboratories, Webster,
TX). Total GLP-1 (GLPIT-36HK; Linco
Research,St.Charles,MO),totalGIP,and
CCK-8 were measured by radioimmuno-
assay (6).
Cardiovascular autonomic function
wasassessedbythevariationinR-Rinter-
valduringdeepbreathingandthesystolic
blood pressure changes in response to
standing (7).
Data were evaluated using repeated-
measures ANOVA with treatment and
time as factors (StatView 5.0; Abacus
Concepts, Berkeley, CA). Data are shown
as means  SE; P  0.05 was considered
signiﬁcant.
RESULTS— Two of the eight subjects
had deﬁnite autonomic dysfunction. The
study was well tolerated.
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days, emptying was rapid initially and
subsequently slower, whereas emptying
after the whey preload approximated a
linear pattern. Gastric emptying was
slowest on the whey preload day (T50:
87.3  5.4 min; P  0.0001) and was
slower with whey in the meal (53.0  8.3
min; P  0.01) than with no whey
(39.0  6.2 min).
There were no differences in baseline
blood glucose, plasma insulin, GLP-1,
GIP, or CCK concentrations (Fig. 1). The
incremental area under the curve (iAUC)
for blood glucose was less after the whey
preload (363.7  64.5 mmol   min
1  
l
1) and whey in meal (406.3  85.9
mmol   min
1   l
1) compared with no
whey (734.9  98.9 mmol   min
1   l
1;
P  0.005 for both). The iAUCs for insu-
lin, GLP-1, GIP, and CCK were greater
when whey was given as a preload (P 
0.05 for all) or in the meal (P  0.005 for
all) compared with no whey. Despite an
Figure 1—Gastric emptying (A), concentrations of blood glucose (B), plasma insulin (C), plasma GLP-1 (D), plasma GIP (E), and plasma CCK
(F)inresponsetoamashedpotatomealineighttype2diabeticpatients.Oneachstudyday,subjectsingested350mlbeef-ﬂavoredsoup30minbefore
a radiolabeled mashed potato meal; 55 g whey protein was added either to the soup (whey preload) or to the potato (whey in meal) or no whey was
given (no whey). Data are means  SE. *P  0.05, whey preload vs. whey in meal; #P  0.05, whey in meal vs. no whey; §P  0.05, whey preload
vs. no whey.
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not differ between whey preload and
whey in meal (P  0.50). GLP-1 was
greater between 15 min and 90 min
with the whey preload compared with
whey in meal (P  0.0001), but the over-
all iAUC did not differ signiﬁcantly.
CONCLUSIONS — We demon-
strated that whey protein, when given be-
fore or with a high-carbohydrate meal,
resultedinasubstantialreductioninpost-
prandial glycemia in diet-controlled type
2 diabetic patients. Given that the magni-
tude of the reduction was comparable
withwhatwouldbehopedforusingphar-
macological therapy, such as sulfonyl-
ureas, these data have considerable
implications for nutritional strategies in
the management of diabetes.
Thepivotalroleofthegastrointestinal
tract in determining postprandial glyce-
mia has often been overlooked, but it is
assuming increasing prominence, partly
because of the development of gut pep-
tide–based therapies for diabetes, such as
the GLP-1 analog exenatide (8) and the
amylin analog pramlintide (9), which
mayactpredominantlybyslowinggastric
emptying.Similartowhatwereportedaf-
teranoilpreload(4),wheyslowedgastric
emptying substantially, in particular
when given before the meal, and is asso-
ciated with the stimulation of GLP-1 and
CCK. However, in contrast to the delayed
insulin response observed after oil, whey
augmented insulin secretion markedly,
possibly by a combination of the incretin
effect and the direct stimulation of the
-cellsbyabsorbedaminoacids(10).Itis
likely that the stimulation of insulin by
whey was responsible for the much
greater reduction in glycemia after whey
thanafteroil,giventhattheeffectsongas-
tric emptying were comparable.
Although our study involved a small
number of subjects who had well-
controlled, predominantly uncompli-
catedtype2diabetes,theimprovementin
postprandial glycemia was marked and
highly consistent. Further evaluation is
now required in poorly controlled pa-
tients and those taking oral hypoglycemic
agents in order to determine whether the
acute effects are sustained in the longer
term. It would also be important to con-
ﬁrmwhethertheeffectsareevidentwitha
smaller load of protein in order to mini-
mize additional energy intake. Although
concernshavebeenraisedabouthyperin-
sulinemia as a risk factor for vascular
disease (11), it is more likely that it rep-
resents a marker for other risk factors
(12), and in the UK Prospective Diabetes
Study (UKPDS), stimulation of insulin by
sulfonylureas was not associated with in-
creased cardiovascular events (13).
The concept of using dietary manip-
ulations to treat type 2 diabetes, based on
our knowledge of the contribution of gas-
tric emptying and gut peptides to post-
prandial glycemic responses, appears to
hold much promise.
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